Public Agenda NewsPaperPublic Agenda NewsPaper
  • General News
  • Politics
  • Business
  • Health
  • Development Agenda
  • World News
  • Features & Opinions
  • Election watch
  • Editorial
Font ResizerAa
Public Agenda NewsPaperPublic Agenda NewsPaper
Font ResizerAa
  • General News
  • Politics
  • Business
  • Health
  • Development Agenda
  • World News
  • Features & Opinions
  • Election watch
  • Editorial
Search
  • General News
  • Politics
  • Business
  • Health
  • Development Agenda
  • World News
  • Features & Opinions
  • Election watch
  • Editorial
Follow US
Breaking NewsHealth

COVID-19 treatment; EXIMBANK/Tobinco partnership laudable

Latifa Carlos
Last updated: May 4, 2020 11:20 pm
Latifa Carlos
Share
3 Min Read
SHARE

As the global search for COVID-19 treatment heats up in various laboratories, different antiviral and other drugs are being used by medical practitioners to help infected people recover.

Some of these drugs have proven to be efficacious in aiding the recuperation of more than one million people out of the over 3.35 million cases recorded as of yesterday.

Unfortunately, over 230,000 people have passed on to eternity since the respiratory disease caused by the novel coronavirus, started spreading in December last year.

More Read

$100m legal war erupts between E&P and Azumah Resources
Ghana to attract more global oil investors after Akoma and Eban 1X discoveries
Govt cracks down on illegal mining task forces amid extortion claims
Dr. Adrian Alter appointed new IMF resident representative for Ghana
Ablekuma North: EC to rerun Parliamentary Election in 19 Polling Stations

In Ghana, out of the 2,169 confirmed cases, 229, representing about 10 per cent have recovered and discharged with 18 others dead, whereas more than 1,000 people are responding well to treatment.

Two drugs helping the treatment of infected people globally are Hydroxychloroquine and azithromycin. Their efficiency has made them, especially Hydroxychloroquine, a sought after commodity.

However, these, medicines are not produced on a large scale locally while the value of the drugs have surged on the international market due to their acclaimed potency.

It is in view of this that the Ghanaian Times applauds the collaboration between the EXIMBANK Ghana and Entrance Pharmaceuticals and Research Centre, a subsidiary of the TOBINCO group of companies, to mass produce these drugs.

According to the story on our front page, EXIMBANK is set to advance a $5 million facility to Entrance Pharmaceuticals and Research Centre, based at Spintex, a suburb of Accra for the project.

The project, when actualised, would boost the country’s capacity to treat more infected people who are currently receiving treatment at various facilities and homes across the country.

This means that the chances of a good number of the infected patients recovering faster is now higher than ever before, an indication that with adherence to safety protocols, the country would be out the woods soon.

This is welcoming news because as the case count increases in the country, the recovery rate has been an issue of concern to many, especially when there is no certified cure or vaccine.

The ability of various institutions in the country to find a cure and even a vaccine for COVID-19 has never been in doubt but the lack of financial investment has often been a challenge.

The EXIMBANK’s facility to TOBINCO, one of the biggest pharmaceutical companies in the sub region, would give TOBINCO a shot in the arm to rise to the occasion and do more in the fight against the virus.

They have shown the way and we urge other financial institutions to provide similar support to our research institutes so they could come out with a vaccine and cure for COVID-19.

We look forward to the outcome of the EXIMBANK and TOBINCO partnership and wish them all the best.

Source: Ghanaian Times

Share This Article
Facebook Whatsapp Whatsapp Email Copy Link Print

Latest News

Ghana secures $370M from IMF after successful review
July 8, 2025
Mid-Year budget to clarify road contractor payments – Ampem Nyarko
July 2, 2025
 ISODEC Urges Citizens to Engage More in Local Governance Processes 
July 2, 2025
Mfantseman Youth Trained to Strengthen Local Governance Participation 
July 2, 2025
Government Reaffirms Commitment to Investment-Friendly Environment to Attract Development Financing
July 1, 2025
New UN report charts path out of debt crisis threatening global development
June 30, 2025
World Bank backs Ghana $360m to strengthen macroeconomic stability
June 30, 2025

You Might Also Like

Breaking NewsElection watchtop stories

GJA holds national and regional elections today

June 30, 2025
Breaking NewsBusinesstop stories

PURC announces 2.45% increase in Electricity tariffs from July 1

June 26, 2025
Breaking NewsBusinesstop stories

Iran cannot unilaterally shut Strait of Hormuz – NPA boss

June 23, 2025
Breaking NewsBusinesstop stories

Israel-Iran war: Fuel prices likely to rise in July – COPEC

June 23, 2025

About Us

Public Agenda is fou­nded and owned by Pu­blic Agenda Communic­ations.

Public Agenda was founded as a public interest Me­dia entity. Its Visi­on is to contribute to building a well-i­nformed society where accurate informati­on dissemination is the cornerstone of a democratic, just and equitable society.

Its mission is to inform, guide and bui­ld responsible citiz­enship and accountab­le decision making and strive for excell­ence in the media in­dustry. Public Agenda Communications is managed by a Board of Directors.

Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?